本页面由Tiger Trade Technology Pte. Ltd.提供服务

Champions Oncology, Inc.

5.82
+0.12002.11%
成交量:184.00
成交额:1,078.48
市值:8,081.84万
市盈率:-34.24
高:5.82
开:5.82
低:5.82
收:5.70
52周最高:9.63
52周最低:5.50
股本:1,388.63万
流通股本:518.91万
量比:0.82
换手率:0.00%
股息:- -
股息率:- -
每股收益(TTM):-0.1700
每股收益(LYR):0.3300
净资产收益率:-47.59%
总资产收益率:-4.70%
市净率:18.87
市盈率(LYR):17.64

数据加载中...

2022/12/13

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/10/20

重要事件披露

8-K - Current report
2022/09/12

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/09/08

重要事件披露

8-K - Current report
2022/07/22

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2022/07/21

重要事件披露

8-K - Current report
2022/03/15

重要事件披露

8-K - Current report
2022/03/15

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/12/13

重要事件披露

8-K - Current report
2021/12/13

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/11/09

持股变动声明

4 - Statement of changes in beneficial ownership of securities
2021/11/09

持股变动声明

4 - Statement of changes in beneficial ownership of securities
2021/11/09

持股变动声明

4 - Statement of changes in beneficial ownership of securities
2021/11/09

持股变动声明

4 - Statement of changes in beneficial ownership of securities
2021/11/09

持股变动声明

4 - Statement of changes in beneficial ownership of securities
2021/10/19

持股变动声明

4 - Statement of changes in beneficial ownership of securities
2021/10/13

持股变动声明

4 - Statement of changes in beneficial ownership of securities
2021/07/26

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/07/23

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals